Core Viewpoint - The recent leadership change at Wandong Medical involves the resignation of Chairman Ma Chibing after only seven months, with Wang Jianguo, an executive from Midea Group, taking over as the new chairman [1][3]. Group 1: Leadership Changes - Ma Chibing submitted his resignation due to personal reasons, stepping down from multiple roles including Chairman and member of various committees [1][2]. - Wang Jianguo, the new chairman, has a long history with Midea Group, having held various senior positions since 1999 [4]. Group 2: Company Performance - Wandong Medical's performance has been declining, with net profits of 183 million yuan in 2021 and 175 million yuan in 2022, indicating a downward trend [4]. - In the first three quarters of 2025, the company reported revenues of 1.189 billion yuan, an increase of 8.73% year-on-year, but faced a net loss of 27.21 million yuan, a decline of 123.51% [4]. Group 3: Profitability Metrics - The company's gross margin has been under pressure, with a gross margin of 32.62% in the first three quarters of 2025, continuing a downward trend from 45.82% in 2021 to 36.55% in 2024 [5][6]. - The gross margin figures for the years 2021 to 2024 were 45.82%, 44.11%, 42.07%, and 36.55%, respectively, showing a consistent decline [5][6].
仅7个月,万东医疗又换董事长:美的集团执行董事“空降”